Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse
Publication Type:
Journal Article
Authors:
Ho, S.B.;
Brau, N.;
Cheung, R.;
Liu, L.;
Sanchez, C.;
Sklar, M.;
Phelps, T.E.;
Marcus, S.G.;
Wasil, M.M.;
Tisi, A.;
Huynh, L.;
Robinson, S.K.;
Gifford, A.L.;
Asch, S.M.;
Groessl, E.J.Source:
Clin Gastroenterol Hepatol, Volume 13, Issue 11, p.2005-2014.e1-3 (2015)
Keywords:
Antiviral Agents,
Behavioral Medicine,
Boston,
California,
Case Management,
chronic HCV,
Depression,
Disease,
Face,
Family,
Fibrosis,
Gastroenterology,
Genotype,
genotype 1,
HCV,
Health,
Health Policy,
Health Services,
Health Services Research,
hepatitis,
Hepatitis C,
hepatitis C virus,
Infection,
interventions,
Liver,
Massachusetts,
Medicine,
Mental Health,
methods,
New York,
Odds Ratio,
Patients,
PROVIDE,
psychiatric,
Psychiatry,
Public Health,
Research,
Risk,
strategies,
sustained virologic response,
SVR,
therapy,
treatment,
United States,
Universities,
Veterans
